Cell Point India Ltd
Fundamental Score
Cell Point India Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of CELLPOINT across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Strong Revenue Growth (15.26%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Balanced Promoter Holding (73.06%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
13 factors identified
Below-Average Return on Equity (0.51%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (4.77%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Margin Pressure Concerns (3.81%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Profit Decline Concern (-13.64%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Limited Growth History (2.74% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.
Weak Earnings Growth (-57.37% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Stagnant Profit Growth (-25.39% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity. Assess transformation initiatives.
Weak Interest Coverage (1.07x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
Negative Free Cash Flow (₹-23.68 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Cell Point India Ltd
About CELLPOINT
Company Details
CELLPOINT Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Cell Point India Ltd (CELLPOINT)?
As of 29 Jan 2026, 10:33 am IST, Cell Point India Ltd (CELLPOINT) is currently trading at ₹16.50. The stock has a market capitalization of ₹32.32 (Cr).
Is CELLPOINT share price Overvalued or Undervalued?
CELLPOINT is currently trading at a P/E ratio of 38.48x, compared to the industry average of 39.01x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Cell Point India Ltd share price?
Key factors influencing CELLPOINT's price include its quarterly earnings growth (Sales Growth: 15.26%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Cell Point India Ltd a good stock for long-term investment?
Cell Point India Ltd shows a 5-year Profit Growth of -25.39% and an ROE of 0.51%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.90 before investing.
How does Cell Point India Ltd compare with its industry peers?
Cell Point India Ltd competes with major peers in the Speciality Retail. Investors should compare CELLPOINT's P/E of 38.48x and ROE of 0.51% against the industry averages to determine its competitive standing.
What is the P/E ratio of CELLPOINT and what does it mean?
CELLPOINT has a P/E ratio of 38.48x compared to the industry average of 39.01x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹38 for every ₹1 of annual earnings.
How is CELLPOINT performing according to Bull Run's analysis?
CELLPOINT has a Bull Run fundamental score of 19.6/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does CELLPOINT belong to?
CELLPOINT operates in the Speciality Retail industry. This classification helps understand the competitive landscape and sector-specific trends affecting Cell Point India Ltd.
What is Return on Equity (ROE) and why is it important for CELLPOINT?
CELLPOINT has an ROE of 0.51%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Cell Point India Ltd generates profits from shareholders' equity.
How is CELLPOINT's debt-to-equity ratio and what does it indicate?
CELLPOINT has a debt-to-equity ratio of 0.90, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is CELLPOINT's dividend yield and is it a good dividend stock?
CELLPOINT offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has CELLPOINT grown over the past 5 years?
CELLPOINT has achieved 5-year growth rates of: Sales Growth 2.74%, Profit Growth -25.39%, and EPS Growth -57.37%.
What is the promoter holding in CELLPOINT and why does it matter?
Promoters hold 73.06% of CELLPOINT shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is CELLPOINT's market capitalization category?
CELLPOINT has a market capitalization of ₹32 crores, placing it in the Small-cap category.
How volatile is CELLPOINT stock?
CELLPOINT has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for CELLPOINT?
CELLPOINT has a 52-week high of ₹N/A and low of ₹N/A.
What is CELLPOINT's operating profit margin trend?
CELLPOINT has a 5-year average Operating Profit Margin (OPM) of 3.81%, indicating the company's operational efficiency.
How is CELLPOINT's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 15.26% and YoY Profit Growth of -13.64%.
What is the institutional holding pattern in CELLPOINT?
CELLPOINT has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.